Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...

Explore how the ratio of pd-1+ treg to ctl and the presence of tertiary lymphoid structures can influence treatment outcomes ...

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

Learn about toenail fungus types, symptoms, and prevention methods. Discover what nail changes reveal about your health and immune system.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

This offers hope to some patients who face an average survival rate of just several months. Read more at straitstimes.com.

Former Philadelphia Eagles linebacker Bryan Braman, a Super Bowl LII champion, is fighting a rare and aggressive cancer with ...

CytoDyn announces encouraging clinical findings among patients with advanced metastatic colorectal cancer previously treated with leronlimab: Vancouver, Washington Friday, July 4, ...

A research team led by The University of Osaka finds that elevated levels of certain immune cells in patients with systemic ...